Delivery Order SPE2DB20D2014-SPE2DB24FA16N
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $1,119.93 firm fixed price delivery order is for the supply of Erythromycin 0.5% Eye Ointment 3.5GM to support military treatment programs and facilities. The award has a performance period through March 18, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The $2,066.62 delivery order is for the supply of Erythromycin 0.5% Eye Ointment 3.5GM, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of March 13, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Both companies are...
- The federal contract award summarized here was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,987.93 firm fixed-price delivery order is for the supply of 4,566,688,574 units of Erythromycin 0.5% eye ointment in 3.5 gram packages. The contract has an ultimate completion date of December 12, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,039.76, is for the delivery of Erythromycin 0.5% eye ointment in 3.5 gram tubes. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 27, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds...
- This federal contract award is for the delivery of Erythromycin 0.5% eye ointment to the Defense Logistics Agency (DLA). The $1,777.58 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of December 13, 2022 and was awarded on December 12, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,526.48, is for the delivery of Erythromycin 0.5% Eye Ointment. The contract is a Firm Fixed Price Delivery Order with a completion date of June 14, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Erythromycin 0.5% eye ointment, 3.5 grams, with a ceiling value of $1,507.52 and a completion date of May 13, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award, which...
- This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,243.04 firm fixed-price delivery order contract is for the supply of Erythromycin 0.5% eye ointment to support military healthcare programs. The contract has an ultimate completion date of September 29, 2023 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award is for the delivery of Erythromycin 0.5% eye ointment, 3.5 grams, to the U.S. Department of Defense's Medical Supply Chain, also known as the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,695.55, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 26, 2024. This award is not designated as a set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. The $4,792.64 Firm Fixed Price delivery order is for the supply of 4564435271 - Erythromycin 0.5% Eye Ointment 3.5GM. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FA16NDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,674.12, is for the delivery of Erythromycin 0.5% eye ointment. The award has an ultimate completion date of October 24, 2023 and is structured as a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The contract is not designated as a set-aside award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 10/23/23 |